Literature DB >> 29061779

Identification of 7,8-Diacetoxy-3-Arylcoumarin Derivative as a Selective Cytotoxic and Apoptosis-inducing Agent in a Human Prostate Cancer Cell Line.

Musiliyu A Musa1, Lekan M Latinwo2, Moise Y Joseph2, Veera L Badisa2.   

Abstract

BACKGROUND/AIM: Coumarins are a member of the benzopyrone family of compounds with diverse and interesting pharmacological properties. In the present study, we report the in vitro cytotoxicity evaluation of 7,8-Diacetoxy-3-arylcoumarin derivatives (5a-h) in human prostate (PC-3) and breast (MDA-MB-231) cancer cell lines.
MATERIALS AND METHODS: The cytotoxic activity was evaluated using crystal violet dye-binding assay. Furthermore, the most active compound in vitro cytotoxic activity in human non-cancerous cell line and its effect on the cell-cycle phases, apoptosis proteins expression, mitochondrial membrane potential (MMP), reactive oxygen species (ROS) production and Glutathione (GSH) level were performed.
RESULTS: Among the eight compounds that were evaluated, 7,8-Diacetoxy-3-(4-methylsulfonyl phenyl)coumarin (5f) was the most active derivative with highest cytotoxic activity and selectivity against the PC-3 cell line vs. the non-cancerous WPE1-N22 cell line. The cytotoxic action of compound 5f in PC-3 cells is associated with the cell-cycle arrest at -G0/G1 phase, apoptosis, loss in mitochondrial membrane potential (MMP), induced reactive oxygen species (ROS) production and depletion of Glutathione (GSH) level.
CONCLUSION: The result indicates that the presence of p-methylsulfonylphenyl group on compound 5f is critical in modulating selective cytotoxic activity and induction of apoptosis via the mitochondrial apoptotic signaling pathway that is independent of cytochrome c release. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  3-Arylcoumarin; anticancer; apoptosis; cell cycle; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 29061779     DOI: 10.21873/anticanres.12047

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  A Review on Anti-Tumor Mechanisms of Coumarins.

Authors:  Yi Wu; Jing Xu; Yiting Liu; Yiyu Zeng; Guojun Wu
Journal:  Front Oncol       Date:  2020-12-04       Impact factor: 6.244

2.  Coumarin Sulfonamides and Amides Derivatives: Design, Synthesis, and Antitumor Activity In Vitro.

Authors:  Jing Zhang; Yaling Tan; Guorong Li; Lexian Chen; Minyi Nie; Zhaohua Wang; Hong Ji
Journal:  Molecules       Date:  2021-02-03       Impact factor: 4.411

Review 3.  Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives.

Authors:  Qiang Zhang; Yu-Hang Miao; Teng Liu; Yin-Ling Yun; Xiao-Ya Sun; Tao Yang; Jie Sun
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.